Fat Science

Metabolic medications work by mimicking natural gut hormones and brain signals, not just by slowing down the digestive tract.Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down the rapidly evolving landscape of metabolic therapies. From oral options to high-dose formulations and pipeline molecules, the conversation cuts through public confusion to focus on biological mechanisms.The discussion explores how these therapies interact with complex melanocortin and hormonal pathways in the brain. Rather than relying on rigid protocols or escalating doses prematurely, effective metabolic care focuses on individual biological response and measurable health parameters.Key TakeawaysModern metabolic therapies are designed to mimic native hormones like GLP-1, GIP, and amylin rather than simply slowing gastric emptying.Clinical trial dosing sequences are designed for regulatory approval, while individualized clinical practice prioritizes symptom stability and health markers over reaching maximum doses.Health improvements such as blood pressure regulation, cholesterol shifts, and liver markers often occur independently of scale changes.Resources MentionedDiabesity Institute Foundations CourseCooper Center for MetabolismConnect with UsPodcast Home:fatsciencepodcast.comCooper Center for Metabolism:coopermetabolic.comDiabesity Institute: diabesityinstitute.orgResources from Dr. Cooper:coopermetabolic.com/resourcesJoin Our Community:patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.Produced by: Podcast Impact Studio https://podcastimpactstudio.com

What do new drug reports really mean for your treatment?Explore groundbreaking updates on potential diabetes and weight-loss drugs from Novo Nordisk and Eli Lilly. Dr. Emily Cooper dives into top-line results, explaining what these findings mean for those struggling with metabolic issues.KEY TAKEAWAYSUnderstanding the difference between efficacy estimand and treatment policy estimand.Cagrisema’s potential in aiding weight loss compared to Mounjaro in patients with type 2 diabetes.Semaglutide's effectiveness in children and its implications.NOTABLE QUOTE"Many of our patients with metabolic dysfunction have increased cardiometabolic risk." — Dr. Emily CooperLINKS & RESOURCESLearn more about Diabesity Foundations: learn.diabesityinstitute.orgPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comDiabesity Institute: diabesityinstitute.orgResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Can metabolic dysfunction be the cause of anxiety?Join Dr. Emily Cooper, Andrea Taylor, and guest Alessio De Martis as they explore the fascinating intersection of metabolic health, anxiety, and the struggle with traditional diet advice. Learn how under-fueling can exacerbate metabolic issues and what that means for your overall health. KEY TAKEAWAYSAlessio's experience highlights the struggle of self-managing metabolic health in Europe.Under-fueling can worsen metabolic dysfunction, disrupting body stability.The body's response to hypoglycemia can mirror symptoms of anxiety. NOTABLE QUOTE"If you have a history of hypoglycemia, you're gonna have a lot less tolerance than other people." — Dr. Emily Cooper GUEST BIOAlessio De Martis is a 41-year-old listener from Rome, Italy, who shares his experiences with metabolic dysfunction, hypoglycemia, and anxiety. His journey represents the challenges faced by many in understanding their metabolic health. Links & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Have you ever wondered why your body holds onto weight despite your best efforts?In this eye-opening episode, Dr. Cooper reveals groundbreaking research showing that 100% of healthy adults carry at least six different plastic-related chemicals in their bodies daily. These endocrine disruptors don't just affect your hormones - they may be stored in your fat tissue and could be a hidden driver of metabolic dysfunction. The good news? New Australian research proves you can dramatically reduce these chemicals in just one week with targeted changes.KEY TAKEAWAYSEvery single person tested had at least 6 plastic chemicals in their urine, with food packaging being the primary sourceParticipants cut phthalate levels by 38-54% and BPA by 60% in just 7 days with adjustments in reducing plastic exposure in food and food packagingUltra-processed foods introduce plastic chemicals through multiple processing and packaging stepsCertain chemicals like DEHP may be stored in fat tissue and released during weight lossHeat accelerates plastic migration into food - avoid microwaving in plastic and pouring hot food into plastic containersSimple swaps like choosing fresh over canned foods and using glass containers make significant impactsThe EPA research office studying these chemicals was recently eliminated, removing key consumer protectionsNOTABLE QUOTE"People who switched to the low plastic food and kitchenware cut the phthalates excretion by 38 to 54% in one week and they cut their BPA excretion by 60% in one week." — Dr. Emily CooperLinks & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Could you have metabolic dysfunction even at a normal weight?This episode challenges everything we've been taught about weight and health. Dr. Cooper reveals that up to 25% of normal-weight people have metabolic syndrome, yet they're rarely screened because doctors assume they're healthy based on appearance alone.KEY TAKEAWAYSWeight and metabolic health are not the same thing - you can be metabolically unhealthy at any sizeNormal weight people with metabolic dysfunction are often overlooked and undertreated by healthcare providersKey screening tests include fasting glucose, insulin, HbA1c, triglycerides, HDL cholesterol, blood pressure, and inflammatory markers like HSCRPMetabolic dysfunction can start in your 20s and take decades to develop into serious diseaseBoth normal weight and higher weight patients face bias - normal weight people aren't screened enough, while higher weight people have everything blamed on their weightEarly screening and treatment can prevent catastrophic health outcomes later in lifeThe liver plays a crucial role in metabolism and can become insulin resistant regardless of body weightNOTABLE QUOTE"You cannot tell anything about someone's health from their outside, what they look like or what, even what they're doing necessarily, but definitely not their body size. So you can be healthy or unhealthy at any size body, and I think that's what's overlooked quite a bit." — Dr. Emily CooperLinks & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected]: Key ReferencesPrimary literature supporting this episode• Wang et al. Prevalence of Metabolically Unhealthy Normal Weight and Its Influence on the Risk of Diabetes. Journal of Clinical Endocrinology & Metabolism, 2023.• Review: Beyond BMI — Rethinking Obesity Metrics and Cardiovascular Risk in the Era of Precision Medicine. Journal of Clinical Medicine, December 2025.• Korean meta-analyses on metabolic dysfunction phenotypes and cardiometabolic risk, Cardiovascular and Metabolic Sciences Journal review, 2024.• Frontiers in Nutrition, January 2026. Associations of metabolic heterogeneity with the progression of cardiometabolic multimorbidity.• International Journal of Obesity, September 2025. Cardiovascular risk factors associated with metabolic health phenotypes.Mechanism references• MASLD — metabolic dysfunction-associated steatotic liver disease — nomenclature and clinical framework. AASLD/EASL consensus, 2023.• Insulin signaling, adipose tissue dysfunction, and ectopic fat deposition — reviews on the upstream-downstream relationship.• Epicardial adipose tissue and cardiovascular dysfunction — Frontiers in Cardiovascular Medicine, January 2026.Fat Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Ever wonder why you can improve your health but still feel like you're failing because the scale isn't cooperating?Dr. Cooper breaks down groundbreaking new clinical guidelines from three major obesity organizations that are completely reframing what success in obesity treatment actually means. For the first time, these groups are saying quality of life, energy levels, and overall health matter more than the number on the scale.KEY TAKEAWAYSThree major obesity organizations worked collaboratively to issue guidelines prioritizing quality of life over weight loss as primary treatment goalsGuidelines explicitly address medical stigma as a structural barrier to care requiring systemic changeTreatment is positioned as long-term management similar to other chronic conditions like thyroid disordersDocument notably avoids calorie restriction language, focusing instead on healthy lifestyle alongside medicationSetmelanotide receives strong recommendation for rare genetic obesity conditions with available genetic testingStrong medication recommendations now include GLP-1s like semaglutide and tirzepatide, plus bupropion-naltrexone combinationNOTABLE QUOTE"Nobody ever asked. Nobody ever looked. Nobody ever said anything. I was like, 'I think there's something wrong with my metabolism or something because I'm not eating a ton.' They're like, 'Well, you must be.' And I'm like, 'N- n- no, I don't think so. I mean, unless it's happening when I'm sleeping. I don't know.'" — Andrea TaylorReference LinkAlexander L, Purnell JQ, et al. Pharmacological management of obesity in adults: a clinical guidance statement from The Obesity Society, the Obesity Medicine Association, and the Obesity Action Coalition. Obesity. 2026;34(4):851–870. doi:10.1002/oby.70164 https://onlinelibrary.wiley.com/doi/10.1002/oby.70164 Links & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Have you been told it's just calories in calories out while your lived experience says otherwise?In this mailbag episode, Dr. Cooper addresses complex metabolic questions from listeners worldwide. From eating disorders requiring specialized care to GLP-1 plateau management, each question reveals how individual biology trumps one-size-fits-all solutions.KEY TAKEAWAYSEating disorders like anorexia require comprehensive medical team treatment, not self-management approachesSide effects from GLP-1 medications often improve with consistent eating patterns and adequate nutritionThe calories in calories out model ignores the biological complexity of how your body actually burns fuelPCOS responds well to metabolic treatments because it's driven by underlying insulin and hunger hormone imbalancesSleep deprivation and chronic stress significantly impact GLP-1 effectiveness and overall metabolic functionBioidentical progesterone may help perimenopause sleep issues without the metabolic side effects of older formulationsStroke survivors may experience hypothalamic obesity that responds remarkably well to GLP-1 medicationsNOTABLE QUOTE"If that really worked, imagine, you know, would we actually need these sophisticated medications that are so groundbreaking? Would we have had decades and decades, or actually centuries of failed, you know, diet experiences by so many people?" — Dr. Emily CooperLinks & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.

Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down three breaking metabolic health stories in this quick bonus episode — from a newly approved oral GLP-1 to a major price drop for Medicare patients.Links & ResourcesPodcast Home: fatsciencepodcast.comCooper Center for Metabolism: coopermetabolic.comResources from Dr. Cooper: coopermetabolic.com/resourcesJoin Our Community: patreon.com/cw/FatSciencePodcastSubmit Your Question: [email protected] or [email protected] Science is supported by the Diabesity Institute, a nonprofit dedicated to increasing access to effective, science-based metabolic care.Disclaimer: This podcast is for informational purposes only and is not intended as medical advice. Please consult with a qualified healthcare provider for personalized recommendations.